These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. CD47-SIRPα Signaling Induces Epithelial-Mesenchymal Transition and Cancer Stemness and Links to a Poor Prognosis in Patients with Oral Squamous Cell Carcinoma. Pai S; Bamodu OA; Lin YK; Lin CS; Chu PY; Chien MH; Wang LS; Hsiao M; Yeh CT; Tsai JT Cells; 2019 Dec; 8(12):. PubMed ID: 31861233 [TBL] [Abstract][Full Text] [Related]
44. Predominant Rab-GTPase amplicons contributing to oral squamous cell carcinoma progression to metastasis. da Silva SD; Marchi FA; Xu B; Bijian K; Alobaid F; Mlynarek A; Rogatto SR; Hier M; Kowalski LP; Alaoui-Jamali MA Oncotarget; 2015 Sep; 6(26):21950-63. PubMed ID: 26110570 [TBL] [Abstract][Full Text] [Related]
45. Influence of the RPL34 gene on the growth and metastasis of oral squamous cell carcinoma cells. Dai J; Wei W Arch Oral Biol; 2017 Nov; 83():40-46. PubMed ID: 28697409 [TBL] [Abstract][Full Text] [Related]
46. N-myc downstream-regulated gene 1 downregulates cell proliferation, invasiveness, and tumorigenesis in human oral squamous cell carcinoma. Lee JC; Chung LC; Chen YJ; Feng TH; Juang HH Cancer Lett; 2014 Dec; 355(2):242-52. PubMed ID: 25218595 [TBL] [Abstract][Full Text] [Related]
47. Activation of PGK1 under hypoxic conditions promotes glycolysis and increases stem cell‑like properties and the epithelial‑mesenchymal transition in oral squamous cell carcinoma cells via the AKT signalling pathway. Zhang Y; Cai H; Liao Y; Zhu Y; Wang F; Hou J Int J Oncol; 2020 Sep; 57(3):743-755. PubMed ID: 32705252 [TBL] [Abstract][Full Text] [Related]
48. Silencing JARID1B suppresses oncogenicity, stemness and increases radiation sensitivity in human oral carcinoma. Lin CS; Lin YC; Adebayo BO; Wu A; Chen JH; Peng YJ; Cheng MF; Lee WH; Hsiao M; Chao TY; Yeh CT Cancer Lett; 2015 Nov; 368(1):36-45. PubMed ID: 26184998 [TBL] [Abstract][Full Text] [Related]
49. Cancer-associated fibroblast-derived interleukin-1β activates protumor C-C motif chemokine ligand 22 signaling in head and neck cancer. Huang YH; Chang CY; Kuo YZ; Fang WY; Kao HY; Tsai ST; Wu LW Cancer Sci; 2019 Sep; 110(9):2783-2793. PubMed ID: 31325403 [TBL] [Abstract][Full Text] [Related]
50. Loss of RUNX3 expression inhibits bone invasion of oral squamous cell carcinoma. Park J; Kim HJ; Kim KR; Lee SK; Kim H; Park KK; Chung WY Oncotarget; 2017 Feb; 8(6):9079-9092. PubMed ID: 28030842 [TBL] [Abstract][Full Text] [Related]
51. MicroRNA‑495 targets Notch1 to prohibit cell proliferation and invasion in oral squamous cell carcinoma. Lv L; Wang Q; Yang Y; Ji H Mol Med Rep; 2019 Jan; 19(1):693-702. PubMed ID: 30387817 [TBL] [Abstract][Full Text] [Related]
52. LncRNA HOTAIR promotes the invasion and metastasis of oral squamous cell carcinoma through metastasis-associated gene 2. Tao D; Zhang Z; Liu X; Zhang Z; Fu Y; Zhang P; Yuan H; Liu L; Cheng J; Jiang H Mol Carcinog; 2020 Apr; 59(4):353-364. PubMed ID: 31995261 [TBL] [Abstract][Full Text] [Related]
53. CCL18-NIR1 promotes oral cancer cell growth and metastasis by activating the JAK2/STAT3 signaling pathway. Jiang X; Huang Z; Sun X; Zheng X; Liu J; Shen J; Jia B; Luo H; Mai Z; Chen G; Zhao J BMC Cancer; 2020 Jul; 20(1):632. PubMed ID: 32641093 [TBL] [Abstract][Full Text] [Related]
54. MicroRNA 617 Targeting SERPINE1 Inhibited the Progression of Oral Squamous Cell Carcinoma. Zhao C; Liu Z Mol Cell Biol; 2021 May; 41(6):e0056520. PubMed ID: 33820852 [TBL] [Abstract][Full Text] [Related]
55. Long non-coding RNA CCAT1 is a prognostic biomarker for the progression of oral squamous cell carcinoma via miR-181a-mediated Wnt/β-catenin signaling pathway. Li GH; Ma ZH; Wang X Cell Cycle; 2019 Nov; 18(21):2902-2913. PubMed ID: 31599709 [TBL] [Abstract][Full Text] [Related]
56. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance. Su L; Wang Y; Xiao M; Lin Y; Yu L Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995 [TBL] [Abstract][Full Text] [Related]
57. Overexpression of T-type calcium channel Cav3.1 in oral squamous cell carcinoma: association with proliferation and anti-apoptotic activity. Li RF; Man QW; Liu JY; Zheng YY; Gao X; Liu HM J Mol Histol; 2021 Jun; 52(3):511-520. PubMed ID: 33394292 [TBL] [Abstract][Full Text] [Related]
58. Loss of CYLD promotes cell invasion via ALK5 stabilization in oral squamous cell carcinoma. Shinriki S; Jono H; Maeshiro M; Nakamura T; Guo J; Li JD; Ueda M; Yoshida R; Shinohara M; Nakayama H; Matsui H; Ando Y J Pathol; 2018 Mar; 244(3):367-379. PubMed ID: 29235674 [TBL] [Abstract][Full Text] [Related]
59. Downregulation of FAP suppresses cell proliferation and metastasis through PTEN/PI3K/AKT and Ras-ERK signaling in oral squamous cell carcinoma. Wang H; Wu Q; Liu Z; Luo X; Fan Y; Liu Y; Zhang Y; Hua S; Fu Q; Zhao M; Chen Y; Fang W; Lv X Cell Death Dis; 2014 Apr; 5(4):e1155. PubMed ID: 24722280 [TBL] [Abstract][Full Text] [Related]
60. PER1 suppresses glycolysis and cell proliferation in oral squamous cell carcinoma via the PER1/RACK1/PI3K signaling complex. Gong X; Tang H; Yang K Cell Death Dis; 2021 Mar; 12(3):276. PubMed ID: 33723221 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]